Global Herpes Zoster Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In April 2022, A renowned worldwide eye health company, Bausch Health Companies, Inc., has announced that it has signed into an arrangement agreement with its wholly owned subsidiary Bausch + Lomb Corporation

• In March 2020, Pregabalin containers, a common structure to relieve pain caused by nerve damage caused by diabetes or shingles contamination, were dispatched, according to Camber Pharmaceuticals, Inc

The Global Herpes Zoster Market is segmented across diagnosis, treatment and prevention, administration route, and end-user, each addressing specific aspects of managing this viral infection. By diagnosis, the market offers various methods to confirm Herpes Zoster (shingles) infections, including laboratory testing, immunofluorescent microscopy, real-time polymerase chain reaction (PCR), serological testing, and other diagnostic tools. Laboratory testing and PCR are the gold standards, particularly for detecting the varicella-zoster virus, while immunofluorescent microscopy and serological testing help identify viral particles and antibodies, respectively. These diagnostic techniques help physicians determine the presence and stage of the infection, guiding treatment decisions.

By treatment and prevention, the market includes antiviral medications, narcotic medications, anti-inflammatory medications, antihistamines, anticonvulsants, capsaicin, numbing creams, gels, or patches, vaccines, and other treatment modalities. Antiviral drugs such as acyclovir and valacyclovir are crucial in reducing the severity and duration of symptoms when administered early. Narcotics and anti-inflammatory medications are used to manage pain, especially postherpetic neuralgia, a common complication. Antihistamines help relieve itching, while anticonvulsants are often prescribed for nerve pain. Additionally, topical treatments like capsaicin, numbing creams, gels, or patches provide localized relief. The vaccines segment, including the shingles vaccine, plays a key role in the prevention of Herpes Zoster, particularly in older adults who are at higher risk.

By administration route, treatments for Herpes Zoster can be delivered orally, topically, or through other methods. Oral antiviral medications and pain management drugs are common, especially for systemic treatment, while topical creams, gels, and numbing agents are used for localized relief from pain or itching. The route of administration is largely dependent on the severity and location of the infection.

By end-user, the market includes hospitals & clinics, diagnostic centers, research & academic institutes, home care settings, and others. Hospitals and clinics remain the primary settings for diagnosing and treating severe or complicated cases of Herpes Zoster. Diagnostic centers offer specialized testing services, while research and academic institutes contribute to developing new therapies and vaccines. Home care settings are increasingly important for managing mild cases of Herpes Zoster, especially as antiviral and pain management treatments can often be administered at home.Overall, the Herpes Zoster market is evolving with advances in diagnosis, treatment options, and prevention strategies, addressing the diverse needs of healthcare providers and patients. Each segment plays a crucial role in improving outcomes and quality of life for individuals affected by this painful and often recurring condition.

Global Herpes Zoster Segment Analysis

In this report, the Global Herpes Zoster Market has been segmented by Diagnosis, Treatment and Prevention, Administration Route, End User and Geography.

Global Herpes Zoster Market, Segmentation by Diagnosis

The Global Herpes Zoster Market has been segmented by Diagnosis into Laboratory Testing, Immunofluorescent Microscopy, Real-Time Polymerase Chain Reaction (PCR), Serological Testing, and Others.

Laboratory testing is one of the most common approaches, involving the collection of samples, such as skin lesions or bodily fluids, to detect the virus. This method can include various techniques, including PCR for specific viral detection. Immunofluorescent microscopy is another diagnostic method that uses fluorescently labeled antibodies to identify viral particles directly in tissue samples, offering rapid and specific results for VZV detection.

Real-time PCR is a highly accurate and sensitive diagnostic tool used to detect the viral DNA of VZV in patient samples. It is increasingly used for early detection and diagnosis, particularly in cases where other methods may yield less precise results. Serological testing is employed to detect antibodies, specifically IgM and IgG, indicating recent or past exposure to the virus, which helps in diagnosing Herpes Zoster in patients who may not show immediate symptoms or have atypical presentations. The Others category includes additional testing methods that may be used based on the specific requirements or advancements in the field, such as newer molecular or genetic techniques to detect viral presence or monitor disease progression.

This segmentation underscores the variety of diagnostic options available, catering to different clinical needs, such as determining the active infection, differentiating from other conditions, and confirming prior exposure to VZV for preventive measures. Each diagnostic method plays a crucial role in the timely and accurate identification of Herpes Zoster, which is essential for effective treatment and management.

Global Herpes Zoster Market, Segmentation by Treatment and Prevention

The Global Herpes Zoster Market has been segmented by Treatment and Prevention into Antiviral Medications, Narcotic Medications, Anti-Inflammatory Medications, Antihistamines, Anticonvulsants, Capsaicin, Numbing Creams, Gels, or Patches, Vaccines, and Others.

Antiviral medications such as acyclovir, valacyclovir, and famciclovir are pivotal in reducing the severity and duration of Herpes Zoster outbreaks by inhibiting the replication of the varicella-zoster virus, especially when administered early in the course of the disease. Narcotic medications are used for pain management, particularly for severe cases or postherpetic neuralgia, a common complication of shingles that causes persistent pain long after the rash has healed.

Anti-inflammatory medications help reduce inflammation and alleviate pain associated with Herpes Zoster outbreaks, improving overall comfort and preventing further complications. Antihistamines are commonly used to relieve itching and irritation, a common symptom during an active outbreak. Anticonvulsants, such as gabapentin and pregabalin, are frequently prescribed to manage nerve pain, especially in patients experiencing postherpetic neuralgia. Capsaicin, a topical treatment derived from chili peppers, is used to reduce pain and discomfort by desensitizing the affected area. Numbing creams, gels, or patches, such as lidocaine-based products, provide localized pain relief by numbing the skin, offering symptomatic relief during the acute phase of the condition.

Vaccines, such as the shingles vaccine (Shingrix), play a significant role in prevention, particularly in older adults who are at higher risk of developing Herpes Zoster. The vaccine helps reduce the incidence and severity of shingles and prevents complications like postherpetic neuralgia. The Others category includes various adjunct therapies and treatments, such as complementary medicines, that may be used based on individual patient needs or preferences.

Overall, this segmentation highlights the broad range of treatment options available for Herpes Zoster, from antiviral medications aimed at reducing the viral load to pain management therapies and preventive measures. Each segment plays an important role in the comprehensive management of Herpes Zoster, addressing both the immediate symptoms and long-term complications, thereby improving patient outcomes and quality of life.

Global Herpes Zoster Market, Segmentation by Administration Route

The Global Herpes Zoster Market has been segmented by Administration Route into Oral, Topical and Others.

Topical medications, in the form of creams, lotions, or gels, offer localized relief for the pain, itching, and burning associated with shingles outbreaks. This route is particularly suitable for patients with mild cases or those who experience difficulty swallowing pills.

Oral medications reign supreme as the most prevalent route for herpes zoster treatment. Antiviral drugs like acyclovir, valacyclovir, and famciclovir are commonly prescribed in pill form. These medications work by interfering with the virus's replication, shortening the illness duration and mitigating the severity of symptoms. Additionally, they can help reduce the risk of developing postherpetic neuralgia, a chronic neuropathic pain condition that can linger after the shingles rash clears.

Intravenous administration is reserved for severe cases or immunocompromised individuals where a swift and potent response is necessary. This route involves delivering medications directly into a vein, allowing for rapid absorption into the bloodstream and maximizing their effectiveness. This approach is typically used in hospitalized patients or those with weakened immune systems who may not respond adequately to oral medications.

Global Herpes Zoster Market, Segmentation by End User

The Global Herpes Zoster Market has been segmented by End User into Hospitals & Clinics, Diagnostic Centers, Research & Academic Institutes, Home Care Settings and Others.

Hospitals are the primary end user of herpes zoster treatments, accounting for a significant share of the market. This is due to the fact that hospitals are equipped to handle severe cases of shingles, which may require hospitalization for pain management, intravenous antiviral therapy, and other supportive care measures.

Clinics, including dermatologist clinics, pain management clinics, and infectious disease clinics, also play a vital role in the diagnosis and treatment of herpes zoster. Clinics typically manage mild to moderate cases of shingles, offering patients access to antiviral medications, topical pain relievers, and other outpatient treatment options.

The homecare setting is an emerging segment of the herpes zoster market. This growth is attributed to the increasing availability of oral antiviral medications that can be safely administered at home, along with a growing preference for home-based care whenever possible. The homecare segment is expected to witness significant growth in the coming years, driven by factors such as an aging population and rising healthcare costs.

Global Herpes Zoster Market, Segmentation by Geography

In this report, the Global Herpes Zoster Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Herpes Zoster Market Share (%), by Geographical Region, 2024

The global herpes zoster market is expected to witness significant growth in the coming years, driven by a number of factors, including the rising geriatric population, increasing awareness of the disease, and the development of new and effective treatments.

Geographically, the market is expected to be dominated by North America, due to the high prevalence of herpes zoster in the region and the well-established healthcare infrastructure. However, the Asia Pacific region is expected to grow at the fastest pace, owing to the increasing geriatric population and rising disposable incomes in the region. Europe and Latin America are also expected to witness healthy growth in the coming years.

The increasing geriatric population is a major driver of the growth of the herpes zoster market. As people age, their immune systems weaken, making them more susceptible to developing shingles. Additionally, the rising awareness of herpes zoster is leading to an increase in the number of people diagnosed with the disease. This is creating a demand for new and effective treatments for shingles. The development of new shingles vaccines and antiviral medications is expected to further propel the growth of the market.

This report provides an in depth analysis of various factors that impact the dynamics of Global Herpes Zoster Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Key players in Global Herpes Zoster Market include:

• Astellas Pharma Inc.
• Foamix Pharmaceuticals
• Geneone Life Science
• Glaxosmithkline Plc
• Merck & Co.
• Nal Pharma
• Novartis Ag
• F. Hoffmann-La Roche Ltd
• Tsrl

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis